Ramipril Capsule
Product Images NDC 70518-4607

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Ramipril (NDC 70518-4607). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mm1 (Ramipril 5mg 70518 4607 00)

Label for Ramipril Capsule 5 mg oral capsules, repackaged by RemedyRepack Inc. The label indicates a quantity of 50 capsules per box. It includes storage instructions, manufacturer information (Rising Pharma, Inc., Allendale, NJ), and states 'RX ONLY.' The lot number and expiration date fields are blank.*

FDA Label Image

Remedy_label (Remedy Label)

Ramipril 5 mg capsule label showing quantity of 1 capsule. The label includes the NDC 70518-4607-01 and indicates the capsule color as red. It is repackaged by RemedyRepack Inc. in Indiana, PA, with contact information provided. Storage instructions specify keeping medication out of children's reach and storing at 20-25°C, with permitted excursions to 15-30°C. Manufacturer is Rising Pharma, Inc., Allendale, NJ.*

FDA Label Image

Figure 1 (Ramipril Fig1)

A line graph comparing the proportion of patients over days of follow-up between Ramipril and a placebo. The x-axis represents days of follow-up, while the y-axis shows the proportion of patients. The graph includes a statistical significance value (P=0.0001), indicating a notable difference between the Ramipril and placebo groups.*

FDA Label Image

Figure 2 (Ramipril Fig2)

A forest plot presenting relative risk in the Ramipril treatment group compared to placebo. It details various patient subgroups such as cardiovascular disease status, diabetes, age, sex, hypertension, and more, with corresponding patient counts and incidence of composite outcomes in the placebo group. Confidence intervals illustrating risk estimates are shown across these categories.*

FDA Label Image

Chemical Structure (Ramipril Str)

Chemical structure of Ramipril shown as a detailed molecular diagram, including labeled atoms and bonds illustrating its molecular configuration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.